Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory
Also read:- Laurus Labs to acquire subsidiary of ASPEN Pharmacare
The acquisition will further strengthen the company's network in Gujarat and adjoining areas, he added. Shares of Dr Lal PathLabs on Tuesday closed at Rs 1,367.20 per scrip on the BSE, down 1.52 per cent from its previous close.
Also read:- Roche gets USFDA clearance for cobas pro solutions for diagnostics labs
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at firstname.lastname@example.org. Check out more about our bureau/team here